Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry v3.7.0 was added. The older v3.6.6 entry was removed from the study record's revision history.SummaryDifference0.1%

- Check45 days agoChange DetectedA new patch-level revision entry, Revision: v3.6.6, was added to the study record history. The previous patch entry, Revision: v3.6.5, was removed from the visible history.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision tag v3.6.5 is added to the record history and the previous tag v3.6.4 is removed, reflecting an updated build of the page history.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history now includes a new revision entry: Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a platform update reflected in the page's version history.SummaryDifference0.1%

- Check102 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the record history, replacing the previous 'Revision: v3.6.2'. This reflects an update to the page's revision notes.SummaryDifference0.1%

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.